Appoints Indranil Mukherjee as Chief Executive Officer, Asia Pacific and India to drive growth across key markets and advance the company's next phase of strategic expansion New Delhi, 1 June 2026: Poly Medicure Ltd. (NSE: POLYMED | BSE: 531768), India's leading medical device company
In just one year, the healthcare supply chain leader achieves 80% YoY growth, ₹582 crore (including GMV) topline in Q2, and turns EBITDA positive through disciplined execution and strategic realignment. One year ago, Medikabazaar embarked on a strategic path of hypergrowth with a clear focus on profitability.
